ARCHIVES

ACS Concludes That Laetrile Organization Is Insignificant

This article is from The Cancer Letter archive.

Vol. 17 No. 46 | November 29, 1991

Download PDF Visit The Full Archive

Related Articles

Cancer Control Dilemma: What To do With Successful Demonstrations

September 10, 1976

News Analysis by Keith Baggerly: Duke Trials Went On Despite FDA Statements

January 27, 2012

Centers Of Excellence In Interventions Aimed at molecular Targets; Approved On 19-6 Vote

July 2, 1999

NCI Proposes New Grants and Centers For Molecular Target-Based Therapeutics

March 26, 1999

Oral UFT Equivalent To FULV In Stage II and III Colon Cancer

July 30, 2004

White House Yet To Name NCAB, Cancer Panel Members

February 11, 2011